Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management.
Tefferi A, Barbui T.
Am J Hematol. 2023 Sep;98(9):1465-1487. doi: 10.1002/ajh.27002. Epub 2023 Jun 26.
Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies.
Gangat N, Singh A, Ilyas R, Loscocco GG, Elliott M, Begna K, Pardanani A, Tefferi A.
Am J Hematol. 2024 Oct;99(10):1862-1869. doi: 10.1002/ajh.27416. Epub 2024 Jun 12.
First successful pregnancy outcome after intrauterine insemination in a woman with primary infertility and essential thrombocythemia treated with interferon-alpha and aspirin.
Leković D, Gotić M, Ljubić A.
Srp Arh Celok Lek. 2015 Mar-Apr;143(3-4):210-3. doi: 10.2298/sarh1504210l.
Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes: A Systematic Review and Meta-analysis.
Maze D, Kazi S, Gupta V, Malinowski AK, Fazelzad R, Shah PS, Shehata N.
JAMA Netw Open. 2019 Oct 2;2(10):e1912666. doi: 10.1001/jamanetworkopen.2019.12666.
Myeloproliferative neoplasms and pregnancy: Overview and practice recommendations.
Gangat N, Tefferi A.
Am J Hematol. 2021 Mar 1;96(3):354-366. doi: 10.1002/ajh.26067. Epub 2020 Dec 28.
Primary myelofibrosis and pregnancy outcomes after low molecular-weight heparin administration: A case report and literature review.
Bohîlţea RE, Cîrstoiu MM, Ionescu CA, Niculescu-Mizil E, Vlădăreanu AM, Voican I, Dimitriu M, Turcan N.
Medicine (Baltimore). 2017 Nov;96(46):e8735. doi: 10.1097/MD.0000000000008735.
Essential thrombocythemia and pregnancy.
Griesshammer M, Heimpel H, Pearson TC.
Leuk Lymphoma. 1996 Sep;22 Suppl 1:57-63. doi: 10.3109/10428199609074361.
Anagrelide: what was new in 2004 and 2005?
Petrides PE.
Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):399-408. doi: 10.1055/s-2006-942760.
Primary thrombocythaemia: diagnosis and management.
Pearson TC.
Br J Haematol. 1991 Jun;78(2):145-8. doi: 10.1111/j.1365-2141.1991.tb04408.x.
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative Neoplasms.
Bose P, Xiao Z, Hasselbalch HC, Prchal JT, Duan M, Yacoub A, Rampal R, Kiladjian JJ, Hobbs GS, Tashi T, Shimoda K, Kirito K, Gill H, Hou HA, Lee SE, Huang J, Li B, Qin A, Yu LH, Mascarenhas JO, Mesa RA.
Curr Hematol Malig Rep. 2025 Jul 12;20(1):9. doi: 10.1007/s11899-025-00752-3.
